Browsing by Author Marre, Michel

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 27  next >
Issue DateTitleAuthor(s)Citation
2016Absence of Peripheral Pulses and Risk of Major Vascular Outcomes in Patients With Type 2 DiabetesChalmers, John; Li, Qiang; Mohammedi, Kamel; Patel, Anushka; Woodward, Mark; Zoungas, Sophia; Harrap, Stephen; Marre, Michel; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthAbsence of Peripheral Pulses and Risk of Major Vascular Outcomes in Patients With Type 2 Diabetes, Diabetes Care, vol.39, 12, 2016,pp 2270-2277
2009Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in DiabetesCass, Alan; Chalmers, John; de Galan, Bastiaan; Jardine, Meg; MacMahon, Stephen; Neal, Bruce; Ninomiya, Toshiharu; Patel, Anushka; Perkovic, Vlado; Pillai, Avineshwaran; Woodward, Mark; Zoungas, Sophia; Cooper, Mark; Hamet, Pavel; Mancia, Giuseppe; Marre, Michel; Mogensen, Carl-Erik; Poulter, Neil; Williams, Bryan; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; School of Public Health: NH&MRC Clinical Trials Centre; The George Institute for International Health; The George Institute for International HealthAlbuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes, Journal of the American Society of Nephrology, vol.20, 8,pp 1813-1821
2010Association between alcohol consumption and diabetic retinopathy and visual acuity-the AdRem StudyChalmers, John; Neal, Bruce; Patel, Anushka; Woodward, Mark; Adler, A I; Beulens, Joline W. J.; Grobbee, D; Harrap, Stephen B.; Lee, C; Marre, Michel; Poulter, Neil; Stolk, Ronald P.; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International HealthAssociation between alcohol consumption and diabetic retinopathy and visual acuity-the AdRem Study, Diabetic Medicine Online, vol.27, 10, 2010,pp 1130-1137
2012Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholdsChalmers, John; Colagiuri, Stephen; Fulcher, Greg; Neal, Bruce; Patel, Anushka; Woodward, Mark; Cooper, M; de Galan, B; Hamet, Pavel; Harrap, Stephen B.; Heller, Simon; Li, Q; MacMahon, Stephen; Marre, Michel; Ninomiya, T; Poulter, Neil; Travert, F; Zoungas, Sophia; The George Institute for Global Health; Central Clinical School: Medicine; Northern Clinical School: Medicine; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthAssociation of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds, Diabetologia: clinical and experimental diabetes and metabolism, vol.55, 3, 2012,pp 636-643
2013The Association of High-Density Lipoprotein Cholesterol with Cancer Incidence in Type II Diabetes: A Case of Reverse Causality?Chalmers, John; Morton, Jamie; Ng, Martin; Woodward, Mark; Zoungas, Sophia; Cooper, Mark; Mancia, Giuseppe; Marre, Michel; Poulter, Neil; The George Institute for Global Health; Central Clinical School: Heart Research Institute; Central Clinical School: Heart Research Institute; The George Institute for Global Health; The George Institute for Global HealthThe Association of High-Density Lipoprotein Cholesterol with Cancer Incidence in Type II Diabetes: A Case of Reverse Causality?, Cancer Epidemiology, Biomarkers and Prevention, vol.22, 9, 2013,pp 1628-1633
2014Circulating Inflammatory Markers and the Risk of Vascular Complications and Mortality in People With Type 2 Diabetes and Cardiovascular Disease or Risk Factors: The ADVANCE StudyChalmers, John; Hillis, Graham; Li, Qiang; Patel, Anushka; Woodward, Mark; Hamet, Pavel; Harrap, Stephen; Lowe, Gordon; Marre, Michel; Poulter, Neil; Rumley, Ann; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthCirculating Inflammatory Markers and the Risk of Vascular Complications and Mortality in People With Type 2 Diabetes and Cardiovascular Disease or Risk Factors: The ADVANCE Study, Diabetes, vol.63, 3, 2014,pp 1115-1123
2009The combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes; new results from ADVANCEChalmers, John; de Galan, Bastiaan; MacMahon, Stephen; Neal, Bruce; Ninomiya, Toshiharu; Patel, Anushka; Woodward, Mark; Zoungas, Sophia; Grobbee, Diederick; Hamet, Pavel; Heller, Simon; Marre, Michel; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International HealthThe combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes; new results from ADVANCE, Diabetes Care, vol.32, 11,pp 2068-2074
2017Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetesChalmers, John; Colagiuri, Stephen; Mohammedi, Kamel; Woodward, Mark; Zoungas, Sophia; Cooper, M; Harrap, Stephen B.; Mancia, Giuseppe; Marre, Michel; Poulter, Neil; Williams, Bryan; The George Institute for Global Health; Boden Institute; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthComparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes, Cardiovascular Diabetology, vol.16, 1, 2017,pp 1-9
2011Comparison of waist-to-hip ratio and other obesity indices as predictors of cardiovascular disease risk in people with type-2 diabetes: a prospective cohort study from ADVANCEBatty, G. David; Chalmers, John; Czernichow, Sebastien; Huxley, Rachel; Kengne, Andre; Neal, Bruce; Pillai, Avineshwaran; Woodward, Mark; Zoungas, Sophia; de Galan, Bastiaan E.; Grobbee, Diederick E.; Marre, Michel; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; School of Public Health: NH&MRC Clinical Trials Centre; The George Institute for International Health; The George Institute for International HealthComparison of waist-to-hip ratio and other obesity indices as predictors of cardiovascular disease risk in people with type-2 diabetes: a prospective cohort study from ADVANCE, European Journal of Cardiovascular Prevention & Rehabilitation, vol.18, 2, 2011,pp 312-319
2014Do Cardiac Biomarkers NT-proBNP and hsTnT Predict Microvascular Events in Patients With Type 2 Diabetes? Results From the ADVANCE TrialChalmers, John; Hillis, Graham; Li, Qiang; Patel, Anushka; Woodward, Mark; Harrap, Stephen; Marre, Michel; Poulter, N.; Ryan, Louise; Sattar, Naveed; Welsh, P.; Williams, Bryan; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthDo Cardiac Biomarkers NT-proBNP and hsTnT Predict Microvascular Events in Patients With Type 2 Diabetes? Results From the ADVANCE Trial, Diabetes Care, vol.37, 8, 2014,pp 2202-2210
2009Effects of intensive blood glucose control on vascular outcomes in patients with type 2 diabetesBillot, Laurent; Bompoint, Severine; Chalmers, John; de Galan, Bastiaan; Joshi, Rohina; MacMahon, Stephen; Neal, Bruce; Patel, Anushka; Woodward, Mark; Cooper, Mark; Glasziou, Paul; Grobbee, Diederick E.; Hamet, Pavel; Harrap, Stephen B.; Heller, Simon; Liu, Lisheng; Mancia, Giuseppe; Marre, Michel; Mogensen, Carl-Erik; Pan, C; Poulter, Neil; Rodgers, Anthony; Travert, F; Williams, Bryan; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International HealthEffects of intensive blood glucose control on vascular outcomes in patients with type 2 diabetes, New England Journal of Medicine, vol.358,(24),2009,pp 2560-2572
2014Follow-up of blood-pressure lowering and glucose control in type 2 diabetesArima, Hisatomi; Billot, Laurent; Chalmers, John; Colagiuri, Stephen; Hirakawa, Yoichiro; Joshi, Rohina; Li, Qiang; MacMahon, Stephen William; Monaghan, Helen; Neal, Bruce; Patel, Anushka; Perkovic, Vlado; Rodgers, Anthony; Woodward, Mark; Zoungas, Sophia; Cooper, Mark; et al, Various; Glasziou, Paul P; Grobbee, Diederick E.; Hamet, Pavel; Harrap, Stephen; Heller, Simon; Lisheng, Liu; Mancia, Giuseppe; Marre, Michel; Matthews, David. R.; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; Boden Institute; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthFollow-up of blood-pressure lowering and glucose control in type 2 diabetes, The New England Journal of Medicine, vol.371, 15, 2014,pp 1392-1406
2010The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: PreteraxChalmers, John; Colagiuri, Stephen; Kengne, Andre; Neal, Bruce; Patel, Anushka; Woodward, Mark; Grobbee, Diederick E.; Hamet, Pavel; Heller, Simon; Marre, Michel; Pan, C; Zoungas, Sophia; The George Institute for International Health; Central Clinical School: Medicine; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International HealthThe Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax, Diabetologia: clinical and experimental diabetes and metabolism, vol.53, 5,pp 821-831
2014Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetesChalmers, John; Li, Qiang; Patel, Anushka; Woodward, Mark; Zoungas, Sophia; Cooper, Mark; Hamet, Pavel; Harrap, Stephen; Heller, Simon; Marre, Michel; Poulter, Neil; Williams, Bryan; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthImpact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes, Diabetologia, vol.57, 12, 2014,pp 2465-2474
2013The influence of physical activity on vascular complications and mortality in patients with type 2 diabetes mellitusBlomster, Juuso; Chalmers, John; Chow, Clara; Hillis, Graham; Patel, Anushka; Woodward, Mark; Zoungas, Sophia; Harrap, Stephen; Marre, Michel; Poulter, Neil; The George Institute for Global Health; The George Institute for Global Health; Western Clinical School: Medicine (Westmead); The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthThe influence of physical activity on vascular complications and mortality in patients with type 2 diabetes mellitus, Diabetes, Obesity and Metabolism, vol.15, 11, 2013,pp 1008-1012
2014Intensification of medication and glycaemic control among patients with type 2 diabetes - the ADVANCE trialChalmers, John; Colagiuri, Stephen; Kengne, Andre; Neal, Bruce; Patel, Anushka; Van Dieren, Susan; Woodward, Mark; Zoungas, Sophia; Beulens, Joline W. J.; Davis, T. M. E.; Fulcher, Greg R.; Hamet, Pavel; Heller, Simon; Mancia, Giuseppe; Marre, Michel; Peelen, Linda; van der Schouw, Yvonne T; Williams, Bryan; The George Institute for Global Health; Boden Institute; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthIntensification of medication and glycaemic control among patients with type 2 diabetes - the ADVANCE trial, Diabetes, Obesity and Metabolism, vol.16, 5, 2014,pp 426-432
2008Intensive blood glucose control and vascular outcomes in patients with type 2 diabetesBillot, Laurent; Chalmers, John; Joshi, Rohina; MacMahon, Stephen; Neal, Bruce; Patel, Anushka; Woodward, Mark; Cooper, Mark; et, al; Glasziou, Paul; Grobbee, Diederick; Hamet, Pavel; Harrap, Stephen B.; Heller, Simon; Liu, Lisheng; Mancia, Giuseppe; Marre, Michel; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International HealthIntensive blood glucose control and vascular outcomes in patients with type 2 diabetes, New England Journal of Medicine, vol.358,(24),2008,pp 2560-2572
2013Intensive glucose control improves kidney outcomes in patients with type 2 diabetesCass, Alan; Chalmers, John; Jun, Min; Li, Qiang; MacMahon, Stephen; Patel, Anushka; Perkovic, Vlado; Woodward, Mark; Zoungas, Sophia; Cooper, Mark; Hamet, Pavel; Heerspink, Hiddo Lambers; Mancia, Giuseppe; Marre, Michel; Mogensen, Carl-Erik; Poulter, Neil; School of Public Health: Medicine; The George Institute for Global Health; School of Public Health: Public Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthIntensive glucose control improves kidney outcomes in patients with type 2 diabetes, Kidney International, vol.83, 3, 2013,pp 517-523
2009Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)Colagiuri, Stephen; Bebakar, W. M. W.; Brandle, M.; Kamaruddin, N. A.; Le Thi, T. D.; Marre, Michel; Shaw, Jonathan; Strand, J.; Zdravkovic, M; Central Clinical School: MedicineLiraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU), Diabetic Medicine, vol.26,(3),2009,pp 268-278
2016Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ONChalmers, John; Li, Qiang; MacMahon, Stephen William; Neal, Bruce; Perkovic, Vlado; Rodgers, Anthony; Wong, Muh Geot; Woodward, Mark; Zoungas, Sophia; Cooper, Mark; Hamet, Pavel; Harrap, Stephen; Heller, Simon; Mancia, Giuseppe; Marre, Michel; Matthews, David; Poulter, Neil; Williams, Bryan; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; Northern Clinical School: Medicine; The George Institute for Global Health; The George Institute for Global HealthLong-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON, Diabetes Care, vol.39, 5, 2016,pp 694-700